Previous close | 0.0500 |
Open | 0.0600 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 80.00 |
Expiry date | 2022-07-15 |
Day's range | 0.0400 - 0.0600 |
Contract range | N/A |
Volume | |
Open interest | 122 |
In the latest trading session, AbbVie (ABBV) closed at $153.14, marking a +0.53% move from the previous day.
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
AbbVie recently applied for FDA approval of its advanced Parkinson's disease drug candidate. This could be huge considering it's set to lose market exclusivity of Humira.